Influence
July 16, 2020

Regenstrief CEO lauds collaboration in effort to contain COVID-19 during Side Effects panel

Regenstrief CEO lauds collaboration in effort to contain COVID-19 during Side Effects panel

Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., discussed the latest developments in the fight against COVID-19 during a live virtual panel hosted by Side Effects Public Media and Indiana Public Broadcasting.

Dr. Embí spoke about the importance of data to inform decisions during the pandemic. He stated that data-driven decisions in Indiana may have helped the State contain the virus, preventing the healthcare system from being overwhelmed. Dr. Embí helped lead the collaborative effort to create a dashboard visualizing hospitalization data across the state, which supplements information from the Indiana State Department of Health. Tracking data is critical to understanding what could potentially happen with the virus and adjusting as things change, he said.

He also highlighted collaboration as a bright spot amid the outbreak. As cases have spread, businesses and organizations from across Indiana have combined resources and skills to work for the benefit of Hoosiers. Dr. Embí spoke about the Indiana Pandemic Information Collaborative which he helped create to bring together businesses, academic institutions, government leaders, healthcare partners and more together to share knowledge and strategies to fight COVID-19.

“When I look at what states like Indiana have been able to achieve and the degree to which people are working together to try to contain this, rallying across all the different sectors and pooling all of our resources, that gives me a lot of hope,” Dr. Embí told the audience.

Dr. Embí also encouraged everyone to continue to wear masks and socially distance.

Watch the entire panel here

Related News

image of pregnant woman with vaccine acting as protection from COVID virus

National CDC-funded study confirms that mRNA vaccines protect against serious COVID-19 during pregnancy

The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two

Thomas Imperiale

Journal editorial: Regenstrief researcher calls for tailoring colorectal cancer screening for 45-to-49-year-olds

It’s been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Dr. Shaun Grannis on data surveillance of post-COVID conditions

Regenstrief Vice President for Data and Analytics Shaun Grannis, M.D., M.S., discusses the questions that will be investigated in

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Screening tools co-developed by Regenstrief Institute research scientist help clinicians assess and treat vexing symptoms

Widely used scales measure pain, depression, anxiety, suicide risk, cancer fatigue and now symptoms associated with a common dental